Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis.

por Blöchl-Daum, B., Müller, M., Meisinger, V., Eichler, H. G., Fassolt, A., Pehamberger, H.
Publicado 1996

Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer

por Mader, R M, Schrolnberger, C, Rizovski, B, Brunner, M, Wenzel, C, Locker, G, Eichler, H G, Mueller, M, Steger, G G
Publicado 2003

A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials

por Selker, H P, Oye, K A, Eichler, H-G, Stockbridge, N L, Mehta, C R, Kaitin, K I, McElwee, N E, Honig, P K, Erban, J K, D'Agostino, R B
Publicado 2014

“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?

por Eichler, H‐G, Bloechl‐Daum, B, Bauer, P, Bretz, F, Brown, J, Hampson, LV, Honig, P, Krams, M, Leufkens, H, Lim, R, Lumpkin, MM, Murphy, MJ, Pignatti, F, Posch, M, Schneeweiss, S, Trusheim, M, Koenig, F
Publicado 2016

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

por Eichler, H‐G, Baird, LG, Barker, R, Bloechl‐Daum, B, Børlum‐Kristensen, F, Brown, J, Chua, R, Del Signore, S, Dugan, U, Ferguson, J, Garner, S, Goettsch, W, Haigh, J, Honig, P, Hoos, A, Huckle, P, Kondo, T, Le Cam, Y, Leufkens, H, Lim, R, Longson, C, Lumpkin, M, Maraganore, J, O'Rourke, B, Oye, K, Pezalla, E, Pignatti, F, Raine, J, Rasi, G, Salmonson, T, Samaha, D, Schneeweiss, S, Siviero, PD, Skinner, M, Teagarden, JR, Tominaga, T, Trusheim, MR, Tunis, S, Unger, TF, Vamvakas, S, Hirsch, G
Publicado 2015